<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Drug Resist</journal-id><journal-id journal-id-type="iso-abbrev">Infect Drug Resist</journal-id><journal-id journal-id-type="publisher-id">idr</journal-id><journal-title-group><journal-title>Infection and Drug Resistance</journal-title></journal-title-group><issn pub-type="epub">1178-6973</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">11249070</article-id><article-id pub-id-type="publisher-id">455979</article-id><article-id pub-id-type="doi">10.2147/IDR.S455979</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Facile Synthesis of 5-Bromo-<italic toggle="yes">N</italic>-Alkylthiophene-2-Sulfonamides and Its Activities Against Clinically Isolated New Delhi Metallo-<italic toggle="yes">&#x003b2;</italic>-Lactamase Producing <italic toggle="yes">Klebsiella pneumoniae</italic> ST147</article-title><alt-title alt-title-type="running-authors">Noreen et al</alt-title><alt-title alt-title-type="running-title">Noreen et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Noreen</surname><given-names>Mnaza</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8787-1399</contrib-id><name><surname>Bilal</surname><given-names>Muhammad</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2636-238X</contrib-id><name><surname>Usman Qamar</surname><given-names>Muhammad</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9205-4513</contrib-id><name><surname>Rasool</surname><given-names>Nasir</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Mahmood</surname><given-names>Abid</given-names></name><xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Umar Din</surname><given-names>Sobia</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ali Shah</surname><given-names>Tawaf</given-names></name><xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3302-4036</contrib-id><name><surname>Bin Jardan</surname><given-names>Yousef A</given-names></name><xref rid="aff0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bourhia</surname><given-names>Mohammed</given-names></name><xref rid="aff0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ouahmane</surname><given-names>Lahcen</given-names></name><xref rid="aff0009" ref-type="aff">
<sup>9</sup>
</xref></contrib><aff id="aff0001"><label>1</label><institution>Department of Chemistry, Government College University Faisalabad</institution>, <addr-line>Faisalabad</addr-line>, <addr-line>38000</addr-line>, <country>Pakistan</country></aff><aff id="aff0002"><label>2</label><institution>School of Chemistry and Chemical Engineering, Shandong University</institution>, <addr-line>Jinan</addr-line>, <addr-line>250100</addr-line>, <country>People&#x02019;s Republic of China</country></aff><aff id="aff0003"><label>3</label><institution>Institute of Microbiology, Faculty of Life Sciences, Government College, University Faisalabad</institution>, <addr-line>Faisalabad</addr-line>, <addr-line>38000</addr-line>, <country>Pakistan</country></aff><aff id="aff0004"><label>4</label><institution>Division of Infectious Disease and Department of Medicine, University of Geneva</institution>, <addr-line>Geneva</addr-line>, <country>Switzerland</country></aff><aff id="aff0005"><label>5</label><institution>Department of Pharmaceutical Chemistry, Government College University Faisalabad</institution>, <addr-line>Faisalabad</addr-line>, <addr-line>38000</addr-line>, <country>Pakistan</country></aff><aff id="aff0006"><label>6</label><institution>College of Agriculture Engineering and Food Science, Shandong University of Technology</institution>, <addr-line>Zibo</addr-line>, <addr-line>25500</addr-line>, <country>People&#x02019;s Republic of China</country></aff><aff id="aff0007"><label>7</label><institution>Department of Pharmaceutics, College of Pharmacy, King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country></aff><aff id="aff0008"><label>8</label><institution>Department of Chemistry and Biochemistry, Faculty of Medicine and Pharmacy, Ibn Zohr University</institution>, <addr-line>Laayoune</addr-line>, <addr-line>70000</addr-line>, <country>Morocco</country></aff><aff id="aff0009"><label>9</label><institution>Laboratory of Microbial Biotechnologies, Agrosciences and Environment (Biomage), Labeled Research Unit-CNRSTN&#x000b0;4, Cadi Ayyad University</institution>, <addr-line>Marrakesh</addr-line>, <addr-line>40000</addr-line>, <country>Morocco</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Nasir Rasool; Mohammed Bourhia, Email nasirrasool@gcuf.edu.pk; m.bourhia@uiz.ac.ma</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>17</volume><fpage>2943</fpage><lpage>2955</lpage><history><date date-type="received"><day>01</day><month>2</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>6</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 Noreen et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Noreen et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><abstract><sec sec-type="intro"><title>Introduction</title><p>New Delhi Metallo-<italic toggle="yes">&#x003b2;</italic>-lactamase producing <italic toggle="yes">Klebsiella pneumoniae</italic> (NDM-1-KP) sequence type (ST) 147 poses a significant threat in clinical settings due to its evolution into two distinct directions: hypervirulence and carbapenem resistance. Hypervirulence results from a range of virulence factors, while carbapenem resistance stems from complex biological mechanisms. The NDM-1-KP ST147 clone has emerged as a recent addition to the family of successful clones within the species.</p></sec><sec><title>Methods</title><p>In this study, we successfully synthesized 5-bromo-<italic toggle="yes">N</italic>-alkylthiophene-2-sulfonamides (<bold>3a-c</bold>) by reacting 5-bromothiophene-2-sulfonamide (<bold>1</bold>) with various alkyl bromides (<bold>2</bold>) using LiH. We also synthesized a series of compounds (<bold>4a-g</bold>) from compound (<bold>3b</bold>) using the Suzuki-Miyaura cross-coupling reaction with fair to good yields (56&#x02013;72%). Further, we screened the synthesized molecules against clinically isolated New Delhi Metallo-<italic toggle="yes">&#x003b2;</italic>-lactamase producing <italic toggle="yes">Klebsiella pneumoniae</italic> ST147. Subsequently, we conducted in-silico tests on compound <bold>3b</bold> against a protein extracted from NDM-KP ST147 with PDB ID: 5N5I.</p></sec><sec><title>Results</title><p>The compound (<bold>3b</bold>) with favourable drug candidate status, MIC of 0.39 &#x003bc;g/mL, and MBC of 0.78 &#x003bc;g/mL. This low molecular weight compound exhibited the highest potency against the resistant bacterial strains. The in-silico tests revealed that the compound <bold>3b</bold> against a protein extracted from NDM-KP ST147 with PDB ID: 5N5I demonstrated H-bond and hydrophobic interactions.</p></sec><sec><title>Conclusion</title><p>The 5-bromo-<italic toggle="yes">N</italic>-alkylthiophene-2-sulfonamides displayed antibacterial efficacy against New Delhi Metallo-<italic toggle="yes">&#x003b2;</italic>-lactamase producing <italic toggle="yes">Klebsiella pneumoniae</italic> ST147. After the in-vivo trial, this substance might offer an alternative therapeutic option.</p></sec></abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title><p>
<fig position="anchor" id="uf0001"><graphic xlink:href="IDR-17-2943-g0001" content-type="print-only" position="float"/></fig>
</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>NDM-1</kwd><kwd>antibacterial</kwd><kwd>drug resistance</kwd><kwd><italic toggle="yes">Klebsiella pneumoniae</italic></kwd><kwd>ST</kwd><kwd>sulfonamides</kwd></kwd-group><counts><fig-count count="6"/><table-count count="5"/><ref-count count="51"/><page-count count="13"/></counts></article-meta></front><body><sec id="s0001"><title>Background</title><p>The global public health sectors face a grave threat from the emergence of extensively drug-resistant carbapenem-resistant <italic toggle="yes">Klebsiella pneumoniae</italic> (CR-KP). Various mechanisms such as cell wall modification,<xref rid="cit0001" ref-type="bibr">1&#x02013;4</xref> efflux pumps,<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0006" ref-type="bibr">6</xref>
<italic toggle="yes">&#x003b2;</italic>-lactamase production,<xref rid="cit0007" ref-type="bibr">7&#x02013;11</xref> and ribosome targeting<xref rid="cit0012" ref-type="bibr">12&#x02013;15</xref> can lead to antibiotic resistance in these bacteria. If the spread of antibiotic resistance persists, projections indicate that by 2050, the global death toll could reach one person every three seconds, resulting in an economic loss exceeding $100 trillion. The World Health Organization (WHO) identifies CR-KP as a &#x0201c;critical priority pathogen&#x0201d;. These bacteria resist all classes of <italic toggle="yes">&#x003b2;</italic>-lactam antibiotics and other antibiotic categories like aminoglycosides and quinolones. Consequently, they can induce severe clinical conditions such as bacteremia and septicemia.<xref rid="cit0016" ref-type="bibr">16</xref> Thus, new therapeutic strategies are needed to combat antimicrobial resistance. <italic toggle="yes">K. pneumoniae</italic> can cause urinary tract infections, pneumonia, septicemia, and liver abscesses, in both immunocompromised and immunocompetent individuals.<xref rid="cit0017" ref-type="bibr">17</xref> These bacteria are among the top five nosocomial infections worldwide.<xref rid="cit0018" ref-type="bibr">18</xref></p><p>Carbapenem-resistant <italic toggle="yes">K. pneumoniae</italic> poses a significant danger in clinical settings due to their global dissemination and extensive antibiotic resistance phenotypes via mobile genetic elements, causing higher death rates than carbapenem-susceptible strains.<xref rid="cit0019" ref-type="bibr">19&#x02013;21</xref>
<italic toggle="yes">K. pneumoniae</italic> ST147 consists of clades and carbapenemase clusters, including New Delhi Metallo-<italic toggle="yes">&#x003b2;</italic>-lactamase (NDM), VIMs, and OXA-48-like. <italic toggle="yes">K. pneumoniae</italic> ST147 is endemic to some North African countries, Italy, India, and Greece, while <italic toggle="yes">K. pneumoniae</italic> ST307 is endemic to the USA, Colombia, Italy, and South Africa. Genomic analyses suggest that <italic toggle="yes">K. pneumoniae</italic> ST147 has identical <italic toggle="yes">par</italic>C and <italic toggle="yes">gyr</italic>A mutations and likely acquired plasmids with <italic toggle="yes">bla</italic><sub>CTX-M-15</sub> during the early to mid-2000s, contributing to their widespread dissemination worldwide. <italic toggle="yes">K. pneumoniae</italic> ST147 poses widespread dissemination, the ability to trigger fatal infections, and antibiotic resistance, notably pan-resistance.<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0023" ref-type="bibr">23</xref> New Delhi Metallo-<italic toggle="yes">&#x003b2;</italic>-lactamase producing <italic toggle="yes">K. pneumoniae</italic> (NDM-KP) was first identified in Swedish patients hospitalized in New Delhi, India. So far, over 30 NDM variants have been reported in different parts of the world. These pathogens produced resistance to a variety of antibiotics, including carbapenems; therefore, new therapeutic options are the need of the time (<underline><ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/33404261/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/33404261/</ext-link></underline>).</p><p>Sulfonamides have been a widely used class of antibiotics in clinical use since 1968. They are commonly used to treat upper urinary and respiratory tract infections in primary care medicine, as patients tolerate them well, and they are affordable.<xref rid="cit0024" ref-type="bibr">24</xref> Additionally, sulfonamide derivatives are frequently utilized as anti-bacterial and antiviral drugs in chemotherapy.<xref rid="cit0025" ref-type="bibr">25&#x02013;27</xref> Due to their structural similarities, these medications work as competitive antagonists of 4-aminobenzoic acid. Sulfonamides have anti-bacterial properties and work by incorporating 4-amino benzoic acid into the folic acid pathway, inhibiting folate synthase. It prevents bacteria from synthesizing folic acid, reducing the number of purines they can produce.<xref rid="cit0028" ref-type="bibr">28&#x02013;31</xref> Therefore, sulfonamides have a bacteriostatic effect by hindering the formation of folic acid.</p></sec><sec id="s0002"><title>Methodology</title><sec id="s0002-s2001"><title>Chemicals and Instrumentations</title><sec id="s0002-s2001-s3001"><title>General Procedure for the Synthesis of Alkylated Derivatives of 5-Bromothiophene-2-Sulfonamide (3a-c)</title><p>To start the reaction, dissolved 5-bromothiophene-2-sulfonamide (0.413 mmol, 1 eq). in 40 mL of DMF solvent and added LiH (0.413 mmol, 1 eq). Then, alkyl bromides (0.413 mmol, 1 eq). were added to the mixture dropwise in the oven-dried flask. After the addition, stir it at room temperature for three hours. The reaction progress was tracked by TLC. Subsequently, the product was precipitated by introducing water into the mixture. After precipitation, the product was washed with water and subjected to recrystallization, employing methanol as the solvent.<xref rid="cit0032" ref-type="bibr">32</xref></p></sec><sec id="s0002-s2001-s3002"><title>General Procedure for the Synthesis of Different Derivatives of 5-Bromo-N-Propyl Thiophene-2-Sulfonamide via SMC Coupling Reaction (4a-g)</title><p>In a clean, oven-dried flask 5-bromo-<italic toggle="yes">N</italic>-propylthiophene-2-sulfonamide, Pd (PPh<sub>3</sub>)<sub>4</sub> catalyst (5 mol%), aryl boronic acids (0.774 mmol), and potassium phosphate (1.409 mmol) were added. To create an inert environment, the flask was evacuated three times and then filled with argon gas. Subsequently, 1,4-dioxane (5 mL) was added under an inert atmosphere, and the mixture was stirred at 90&#x000b0;C. After 30 minutes, 0.5 mL of water was added while maintaining an argon atmosphere. The solution was further stirred at 90&#x000b0;C for 30 hours until the reaction reached completion. After completion, the reaction mixture was cooled to room temperature and added water and ethyl acetate. The organic layer was separated, filtered, and dried using anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was then concentrated under reduced pressure. To obtain pure products, the reaction mixture underwent purification through column chromatography using a mixture of n-hexane and ethyl acetate. The obtained products were characterized using various spectroscopic techniques.<xref rid="cit0033" ref-type="bibr">33</xref></p></sec></sec><sec id="s0002-s2002"><title>Identification of the Bacterial Strain</title><p>Briefly, 3 mL of blood sample was drawn from a clinically suspected septicemia child (5 years old) in a tertiary care hospital. The blood was placed into the BACTEC/Alert Pead blood culture vial only after receiving ethical approval from the Ethical Review Board, Government College University Faisalabad as per the declaration of Helsinki and the child&#x02019;s parent provided an informed consent. The BACTEC/Alert automated system (BD, UK) incubated the bottles at 37&#x000b0;C for up to 5 days. The positive sample was sub cultured on blood and MacConkey agar (Oxoid, UK) and plates were incubated at 37&#x000b0;C overnight aerobically. The isolate was identified first based on colony morphology and biochemically confirmed utilizing a Gram-negative card and an automatic VITEK 2 compact system (Biomerieux, France).</p></sec><sec id="s0002-s2003"><title>Sequence Typing of K. Pneumoniae</title><p>To determine the sequence typing of <italic toggle="yes">K. pneumoniae</italic>, seven housekeeping genes were selected, namely glyceraldehyde-3-phosphate dehydrogenase (gapA), the <italic toggle="yes">&#x003b2;</italic>-subunit of RNA polymerase (rpoB), malate dehydrogenase (mdh), phosphorene E (phoE), phosphoglucose isomerase (pgi), periplasmic energy transducer (tonB), and translation initiation factor 2 (infB). Each PCR amplicon was extracted from the agarose gel using the QIAquick Gel Extraction Kit from Qiagen (Hilden, Germany) and sent for commercial sequencing at Eurofins Scientific (London, UK). The obtained sequencing data were then analyzed using the <italic toggle="yes">K. pneumoniae</italic> MLST database available at <underline><ext-link xlink:href="http://bigsdb.pasteur.fr/klebsiella/klebsiella.html" ext-link-type="uri">http://bigsdb.pasteur.fr/klebsiella/klebsiella.html</ext-link></underline>.</p></sec><sec id="s0002-s2004"><title>Antibiogram of the Isolate</title><p>Using the automated VITEK 2<sup>&#x000ae;</sup> compact system (BioMerieux, France), the MICs of several antibiotics against the pathogen were calculated. The MIC of the antibiotics is expressed in micrograms per milliliter (&#x000b5;g/mL). The antimicrobials tested were piperacillin; ampicillin/sulbactam; cefepime; levofloxacin; ceftriaxone; aztreonam; amikacin; meropenem; minocycline; moxifloxacin; colistin; tetracycline; chloramphenicol. Susceptibility was interpreted the following CLSI 2021 recommendations.<xref rid="cit0034" ref-type="bibr">34</xref></p></sec><sec id="s0002-s2005"><title>Phenotypic Detection Carbapenemase Enzyme</title><p>The <italic toggle="yes">K. pneumoniae</italic> was subjected to the Modified Hodge&#x02019;s test (MHT) to determine carbapenemase activity.<xref rid="cit0035" ref-type="bibr">35</xref> Briefly, the isolates were streaked onto a Mueller-Hinton agar (MHA) plate, and a meropenem disc was inserted in the middle of the plate for the MHT. After being incubated for a whole day, a disc of meropenem developed a cloverleaf-shaped depression, proving the presence of carbapenemase enzymes. MBL-producing bacteria were identified using the double-disc synergy method with EDTA. Briefly, the <italic toggle="yes">K. pneumoniae</italic> was spread onto MHA, and two discs containing imipenem and meropenem were placed. 10 &#x000b5;L of a 0.5M EDTA solution was applied to each carbapenem disc. A positive result was indicated if the EDTA discs displayed a zone of inhibition more significant than 5 mm compared to the non-EDTA discs.<xref rid="cit0036" ref-type="bibr">36</xref></p></sec><sec id="s0002-s2006"><title>Phenotypic Detection of Metallo-&#x003b2;-Lactamase (MBL) Enzyme</title><p>MBL-producing bacteria were identified using the double-disc synergy method, incorporating EDTA. Briefly, the isolates were spread onto Mueller-Hinton agar (MHA) plates, and two discs containing imipenem and meropenem were positioned 24 mm apart. Subsequently, 10 &#x000b5;L of a 0.5M EDTA solution was applied to each carbapenem disc. A positive result was indicated if the EDTA discs displayed a zone of inhibition greater than 5 mm compared to the non-EDTA discs.<xref rid="cit0036" ref-type="bibr">36</xref></p></sec><sec id="s0002-s2007"><title>Molecular Characterization of bla<sub>NDM</sub></title><p>The extraction of DNA from bacteria culture was carried out using DNA kit for bacterial cell (TIANamp, Beijing, China). PCR reaction was performed using the gene specific primers F1 (5-ATGGAATTGCCCAATATTATGCAC-3) and R1 (5-TCAGCGCAGCTTGTCGGC-3), for the presence of blaNDM. The gene sequences was confirmed and subsequently the NDM variant was sequenced.</p></sec><sec id="s0002-s2008"><title>Anti-Bacterial Activity of the Compound Against NDM-1-KP ST147</title><sec id="s0002-s2008-s3001"><title>Agar Well Diffusion Method</title><p>The agar well diffusion experiment was used to determine whether or not the compounds have anti-bacterial activity against NDM-KP. A bacterial suspension with a turbidity of 0.5 McFarland standard was used to inoculate Mueller Hinton Agar plates. After that, 50, 40, 30, 20, and 10 mg of a DMSO solution containing various concentrations of each sample were added to each well that was previously made on plates. Overnight, the plates were kept at 37 degrees Celsius. A Vernier caliper measured the inhibition zone (in mm) surrounding each well. The <italic toggle="yes">E. coli</italic> (ATCC 25922) and meropenem antibiotics were used as a quality control reference. The experiment was repeated three times to guarantee data accuracy and repeatability.<xref rid="cit0016" ref-type="bibr">16</xref></p></sec><sec id="s0002-s2008-s3002"><title>Minimum Inhibitory Concentration of Different Compounds Against NDM-1-KP ST147</title><p>Micro broth dilution assay determined the MIC (% w/v) of different compounds as described earlier.<xref rid="cit0037" ref-type="bibr">37</xref> To prepare the bacterial culture, in a 50 mL Falcon tube, 20 mL of double-strength lysogeny broth (LB) media was combined with two to three individual colonies. Afterwards, the media were kept at 37 degrees for 24 hours. The bacterial suspension was then diluted to an OD of 0.07 at 600 nm, corresponding to a turbidity of 0.5 McFarland standard. Dimethyl sulfoxide (DMSO) solutions of 0.76, 1.56, 3.12, 6.25, 12.5, 25, and 50 mg of each drug were made for the MIC test. Next, a 96-well, flat-bottom microtiter plate was prepared, and 100 &#x000b5;L of each chemical dilution was applied to each well. The bacterial suspension was then added to each well at a concentration of 100 &#x000b5;L. The wells serving as negative controls each held 100 &#x000b5;L of LB, whereas the wells serving as positive controls held LB along with the bacterial solution. The microtiter plate was kept in a shaking incubator (MaxQTM Mini 4450, Thermo Fisher Scientific) at 3 g and 37 degrees Celsius for a whole night. By comparing the development in each well to that of the negative and positive controls, the MIC value for each chemical was determined. To guarantee reliability and consistency, all experiments were run three times.</p></sec><sec id="s0002-s2008-s3003"><title>Minimum Bactericidal Concentration Against NDM-1-KP ST147</title><p>The Minimum Bactericidal Concentration (MBC), expressed as a percentage w/v, was determined as the first dilution that showed no visible growth on the agar plate. A 10&#x003bc;L sample was taken from wells with no visible growth in the microtiter plate. The sample was then inoculated onto nutrient agar plates and incubated at 37&#x000b0;C for 24 hours aerobically. After incubation, the plates were examined for cell viability, and the presence or absence of bacterial growth was recorded. The entire process was repeated in triplicate to ensure the accuracy and reliability of the results.</p></sec></sec><sec id="s0002-s2009"><title>Docking Studies</title><p>Ligand-receptor docking studies of <bold>3b</bold> were performed using crystal structure <italic toggle="yes">bla</italic><sub>VIM</sub>. Protein was found with a resolution of 2.20 A&#x000b0;. All these docking studies were performed on AutoDock Vina software installed on Intel(R) Core (TM) m3-7Y30 processor 1.00GHz 1.61 GHz and the operating system used is Windows 10 Pro Education version 21H2.<xref rid="cit0038" ref-type="bibr">38</xref></p><p>Protein with PDB ID: 5N5I was selected and downloaded from the RCSB website (<underline><ext-link xlink:href="https://www.rcsb.org/" ext-link-type="uri">https://www.rcsb.org/</ext-link></underline>) in PDB format. The protein contained 232 residues, including zinc metals as cofactors. Crystal protein was prepared using structure preparation wizard. It was protonated 3D and corrected to get corrected bond angles or geometry of protein residues. The energy of protein was minimized to attain optimized geometry. The prepared protein was saved in PDB format.<xref rid="cit0039" ref-type="bibr">39</xref></p><p>A database of ligands was prepared using PubChem and converted to 3D structure by giving input in smiles format. The energy of the ligand was minimized to stabilize the ligand bond angles and geometry. Database files were saved in mdb format.<xref rid="cit0040" ref-type="bibr">40</xref></p><p>The active pocket was selected using a site finder keeping the amino acid residues, zinc metal, and water molecules as reported in previous literature. <bold>3b</bold> was docked this active pocket of crystal protein retaining 70 poses for docking. Validation was done by docking the standard inhibitor (LMP) of the protein back into the active pocket.<xref rid="cit0041" ref-type="bibr">41</xref></p></sec></sec><sec id="s0003"><title>Results</title><sec id="s0003-s2001"><title>Chemistry</title><p>We initiated our work by reacting 5-bromothiophene-2-sulfonamide (<bold>1</bold>) with various alkyl bromides (<bold>2</bold>) in DMF in the presence of LiH at room temperature to synthesize 5-bromo-<italic toggle="yes">N</italic>-alkylthiophene-2-sulfonamides (<bold>3a-c</bold>). To increase their efficacy and product yield, minor structural changes were made to these compounds. Several alkyl bromides were employed to synthesize novel derivatives with valuable biological properties. The alkylation of the free amine led to the completion of the reaction. The compounds 5-bromo-<italic toggle="yes">N</italic>-ethylthiophene-2-sulfonamide (<bold>3a</bold>) and 5-bromo-<italic toggle="yes">N</italic>-propylthiophene-2-sulfonamide (<bold>3b</bold>) were obtained with yields of 72% and 78%, respectively, when treated with bromoethane and 1-bromopropane respectively. The lower yield of 62% obtained for 5-bromo-<italic toggle="yes">N</italic>-isopropylthiophene-2-sulfonamide (<bold>3c</bold>), derived from isopropyl bromide, may have been due to steric hindrance (<xref rid="f0001" ref-type="fig">Figure 1</xref>).
<fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p>Synthesis of 5-bromo-<italic toggle="yes">N</italic>-alkylthiophene-2-sulfonamides.</p></caption><graphic xlink:href="IDR-17-2943-g0002" content-type="print-only" position="float"/></fig></p><p>To create a compound library of 5-bromo-<italic toggle="yes">N</italic>-propylthiophene-2-sulfonamide (<bold>3b</bold>) for further SMC coupling with various aryl boronic acids, resulting in products (<bold>4a-g</bold>) due to promising activity against bacteria. Significantly, compound (<bold>4f</bold>) demonstrated the highest yield at 72%, while compound (<bold>4g</bold>) also exhibited a commendable yield of 68%. Compound (<bold>4c</bold>) and compound (<bold>4e</bold>) yielded lower percentages of 62% and 66%, respectively, whereas compounds (<bold>4b</bold>), (<bold>4a</bold>), and (<bold>4d</bold>) exhibited yields of 58%, 56%, and 62%, respectively. Our data indicate that the yields of Suzuki-coupled products of the alkylated substrate can vary slightly depending on electron-withdrawing and electron-donating substituents (<xref rid="f0002" ref-type="fig">Figure 2</xref>).
<fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p>Arylation of 5-bromo-<italic toggle="yes">N</italic>-propylthiophene-2-sulfonamide.</p></caption><graphic xlink:href="IDR-17-2943-g0003" content-type="print-only" position="float"/></fig></p></sec><sec id="s0003-s2002"><title>Anti-Bacterial Activities</title><sec id="s0003-s2002-s3001"><title>Identification and ST of the Isolate</title><p>The clinical isolate was identified as <italic toggle="yes">K. pneumoniae</italic> belonged to ST147 which was confirmed using the VITEK 2 system and as per PubMed MLST scheme. <italic toggle="yes">K. pneumoniae</italic> ST147 was phenotypically positive for both MBL producer and carbapenemase. The isolate exhibited antibiotic resistance from the WHO&#x02019;s Access, Watch, and Reserve (AWaRe) categories. The MICs of piperacillin (&#x02265;256 &#x000b5;g/mL), levofloxacin (&#x02265;16 &#x000b5;g/mL), meropenem (&#x02265;32 &#x000b5;g/mL), and ceftriaxone (&#x02265;256 &#x000b5;g/mL) were higher than normal. However, colistin (0.5 &#x000b5;g/mL) was the most effective medication with the highest sensitivity against the isolate (<xref rid="t0001" ref-type="table">Table 1</xref>). Molecular identification of <italic toggle="yes">bla</italic><sub>NDM-1</sub> gene showed that Carbapenem-resistant <italic toggle="yes">K. pneumoniae</italic> ST147 carried <italic toggle="yes">bla</italic><sub>NDM-1.</sub><table-wrap position="float" id="t0001"><label>Table 1</label><caption><p>MIC (&#x000b5;g/Ml) of Antibiotics Against K. Pneumoniae ST147 Pathogen</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Antibiotics</th><th rowspan="1" colspan="1">WHO Classes of Antibiotics</th><th rowspan="1" colspan="1">MIC Break Points (ug/mL)</th><th rowspan="1" colspan="1"><italic toggle="yes">K. pneumoniae</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">PIP</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x000a0;&#x02264;16 - &#x02265;128</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;256</td></tr><tr><td rowspan="1" colspan="1">SAM</td><td rowspan="1" colspan="1">Access</td><td rowspan="1" colspan="1">&#x000a0;&#x02264;8/4 - &#x02265;32/16</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;64/32</td></tr><tr><td rowspan="1" colspan="1">SXT</td><td rowspan="1" colspan="1">Access</td><td rowspan="1" colspan="1">&#x02264;2/38 - &#x02265;4/76</td><td rowspan="1" colspan="1">&#x0003e;8/152</td></tr><tr><td rowspan="1" colspan="1">CRO</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x02264;8 - &#x02265;64</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;256</td></tr><tr><td rowspan="1" colspan="1">FEP</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x02264;8 - &#x02265;32</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;128</td></tr><tr><td rowspan="1" colspan="1">MEM</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x02264;2 - &#x02265;8</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;32</td></tr><tr><td rowspan="1" colspan="1">ATM</td><td rowspan="1" colspan="1">Reserve</td><td rowspan="1" colspan="1">&#x000a0;&#x02264;4 - &#x02265;16</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;64</td></tr><tr><td rowspan="1" colspan="1">AK</td><td rowspan="1" colspan="1">Access</td><td rowspan="1" colspan="1">&#x02264;4 - &#x02265;16</td><td rowspan="1" colspan="1">&#x02265;16</td></tr><tr><td rowspan="1" colspan="1">LEV</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x02264;1 - &#x02265;4</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;16</td></tr><tr><td rowspan="1" colspan="1">MNO</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x02264;4 - &#x02265;16</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;64</td></tr><tr><td rowspan="1" colspan="1">MXF</td><td rowspan="1" colspan="1">Watch</td><td rowspan="1" colspan="1">&#x02264;0.5 - &#x02265;2</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;16</td></tr><tr><td rowspan="1" colspan="1">C</td><td rowspan="1" colspan="1">Access</td><td rowspan="1" colspan="1">&#x000a0;&#x02264;8 - &#x02265;32</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;128</td></tr><tr><td rowspan="1" colspan="1">TE</td><td rowspan="1" colspan="1">Access</td><td rowspan="1" colspan="1">&#x02264;4 - &#x02265;16</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;32</td></tr><tr><td rowspan="1" colspan="1">CS</td><td rowspan="1" colspan="1">Reserve</td><td rowspan="1" colspan="1">&#x000a0;&#x02265;4</td><td rowspan="1" colspan="1">&#x000a0;0.5</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Abbreviations</bold>: PIP, Piperacillin; SAM, Ampicillin<italic toggle="yes">/</italic>sulbactam; SXT, Trimethoprim/sulfamethoxazole; CRO, Ceftriaxone; FEP, Cefepime; MEM, Meropenem; ATM, Aztreonam; AK, Amikacin; LEV, Levofloxacin; MNO, Minocycline; MXF, Moxifloxacin; C, Chloramphenicol; TE, Tetracycline; CS, Colistin.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0003-s2002-s3002"><title>Agar Well Diffusion Assay of NDM-1- K. Pneumoniae ST147</title><p>The Results, including the activity, are presented in <xref rid="t0002" ref-type="table">Table 2</xref>. Notably, the zone of inhibition (measured in mm) increased with higher concentrations of the compounds. Among the tested compounds, compound (<bold>3b</bold>) exhibited the highest zone of inhibition, measuring 23 &#x000b1; 1.5 mm, at a concentration of 50 mg/dL (<xref rid="f0003" ref-type="fig">Figure 3</xref>). This zone of inhibition was significantly more significant compared to the other compounds. However, compounds <bold>3a</bold> showed (16&#x000b1;2 mm), <bold>3c</bold> (13&#x000b1;2 mm), <bold>4b</bold> (13&#x000b1;2.5 mm) <bold>4c</bold> (5&#x000b1;3 mm), and <bold>4f</bold> (14&#x000b1;2 mm).<table-wrap position="float" id="t0002"><label>Table 2</label><caption><p>Agar Well Diffusion of Different Compounds Against NDM-KP ST147</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Compounds No.</th><th rowspan="1" colspan="1">Zone (mm) (50mg/mL)</th><th rowspan="1" colspan="1">Zone (mm) (40mg/mL)</th><th rowspan="1" colspan="1">Zone (mm) (30mg/mL)</th><th rowspan="1" colspan="1">Zone (mm) (20mg/mL)</th><th rowspan="1" colspan="1">Zone (mm) (10mg/mL)</th><th rowspan="1" colspan="1">DMSO Zone (mm)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>3a</bold></td><td rowspan="1" colspan="1">16&#x000b1;2</td><td rowspan="1" colspan="1">11&#x000b1;2.5</td><td rowspan="1" colspan="1">8 &#x000b1;1</td><td rowspan="1" colspan="1">8 &#x000b1;3</td><td rowspan="1" colspan="1">7 &#x000b1;2</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"><bold>3b</bold></td><td rowspan="1" colspan="1">23 &#x000b1;1.5</td><td rowspan="1" colspan="1">21 &#x000b1;1</td><td rowspan="1" colspan="1">20 &#x000b1;1</td><td rowspan="1" colspan="1">20 &#x000b1;2</td><td rowspan="1" colspan="1">19 &#x000b1;1</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"><bold>3c</bold></td><td rowspan="1" colspan="1">13 &#x000b1;1</td><td rowspan="1" colspan="1">12 &#x000b1;2</td><td rowspan="1" colspan="1">10 &#x000b1;3</td><td rowspan="1" colspan="1">9 &#x000b1;3</td><td rowspan="1" colspan="1">7 &#x000b1;2.5</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"><bold>4b</bold></td><td rowspan="1" colspan="1">13&#x000b1;2.5</td><td rowspan="1" colspan="1">12&#x000b1;2</td><td rowspan="1" colspan="1">11&#x000b1;2</td><td rowspan="1" colspan="1">10&#x000b1;1</td><td rowspan="1" colspan="1">8&#x000b1;2</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"><bold>4c</bold></td><td rowspan="1" colspan="1">5&#x000b1;3</td><td rowspan="1" colspan="1">4&#x000b1;2.5</td><td rowspan="1" colspan="1">3&#x000b1;1</td><td rowspan="1" colspan="1">2&#x000b1;2.5</td><td rowspan="1" colspan="1">2&#x000b1;2</td><td rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1"><bold>4f</bold></td><td rowspan="1" colspan="1">14&#x000b1;3</td><td rowspan="1" colspan="1">131&#x000b1;1</td><td rowspan="1" colspan="1">12&#x000b1;1</td><td rowspan="1" colspan="1">12&#x000b1;1</td><td rowspan="1" colspan="1">9&#x000b1;1.5</td><td rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap></p></sec><sec id="s0003-s2002-s3003"><title>MIC and MBC of the Compounds Against NDM -KP ST147</title><p>The anti-bacterial activity of the molecules (<bold>3a&#x02013;c, 4a-g</bold>) was evaluated against NDM-producing <italic toggle="yes">K. pneumoniae</italic> ST147 using the agar well diffusion method at five different concentrations (10, 20, 30, 40, and 50 mg/well). The results demonstrated that compound (<bold>3b</bold>) exhibited the lowest MIC and MBC values of 0.39 &#x003bc;g/mL and 0.78 &#x003bc;g/mL, respectively. In comparison, compound (<bold>4c</bold>) displayed a MIC of 1.56 &#x003bc;g/mL and an MBC of 3.125 &#x003bc;g/mL. Furthermore, compound (<bold>3a</bold>) showed a MIC of 3.125 &#x003bc;g/mL and an MBC of 6.25 &#x003bc;g/mL, as presented in <xref rid="t0003" ref-type="table">Table 3</xref>.<table-wrap position="float" id="t0003"><label>Table 3</label><caption><p>MIC (Mg/mL) and MBC of Compounds Against CRKP</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Compounds No.</th><th rowspan="1" colspan="1">MIC (&#x003bc;g/mL)</th><th rowspan="1" colspan="1">MBC (&#x003bc;g/mL)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>3a</bold></td><td rowspan="1" colspan="1">3.125 &#x000b1;2.5</td><td rowspan="1" colspan="1">6.25 &#x000b1;2.5</td></tr><tr><td rowspan="1" colspan="1"><bold>3b</bold></td><td rowspan="1" colspan="1">0.39 &#x000b1;2</td><td rowspan="1" colspan="1">0.78 &#x000b1;2.5</td></tr><tr><td rowspan="1" colspan="1"><bold>3c</bold></td><td rowspan="1" colspan="1">25 &#x000b1;1</td><td rowspan="1" colspan="1">50 &#x000b1;1.5</td></tr><tr><td rowspan="1" colspan="1"><bold>4b</bold></td><td rowspan="1" colspan="1">12.5 &#x000b1;2</td><td rowspan="1" colspan="1">25 &#x000b1;3.0</td></tr><tr><td rowspan="1" colspan="1"><bold>4c</bold></td><td rowspan="1" colspan="1">1.56 &#x000b1;3</td><td rowspan="1" colspan="1">3.125 &#x000b1;2</td></tr><tr><td rowspan="1" colspan="1"><bold>4f</bold></td><td rowspan="1" colspan="1">3.125 &#x000b1;1.5</td><td rowspan="1" colspan="1">6.25 &#x000b1;2</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="s0003-s2003"><title>Docking Studies</title><p>Protein with PDB ID: 5N5I selected having four chains in structure Chain A contained 232 amino acid residues, Chain B had standard inhibitor (LMP) with three zinc metals, and Chain C, and D had water molecules. The compound (<bold>3b</bold>) was docked in the active pocket of crystal structure protein having Amino acid residues, as reported in <xref rid="t0004" ref-type="table">Table 4</xref>.<table-wrap position="float" id="t0004"><label>Table 4</label><caption><p>Description of Active Pockets of the Protein Crystal Structure of 5N5I, Indicating Important Interacting Residues as Well as the Type of Interactions Involved</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">PDB ID</th><th rowspan="1" colspan="1">5N5I</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Amino Acids</bold></td><td rowspan="1" colspan="1">Phe62, Asp63, Tyr67, Pro68, Trp87, His114, His116, Asp117, Asp118, Glu146, Asn148, His179, Gly197, Cys198, Val200, His201, Glu202, Ser205, Ser207, Ala208, Gly209, Asn210, Asp213, Pro238, Gly239, His240, Gly242</td></tr><tr><td rowspan="1" colspan="1"><bold>Water and cofactors</bold></td><td rowspan="1" colspan="1">HOH 445, Zn301, Zn302</td></tr><tr><td rowspan="1" colspan="1"><bold>Types of Interactions</bold></td><td rowspan="1" colspan="1">H.B, pi-pi, Pi- Alkyl, pi- Sulphur, Pi-cation</td></tr></tbody></table></table-wrap>
<table-wrap position="float" id="t0005"><label>Table 5</label><caption><p>Representing Binding Affinity, Interacting Residues as Well as the Type of Interactions for 3b and LMP (Standard Inhibitor) in the Active Pocket of the Target Protein</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Test Ligand</th><th rowspan="1" colspan="1">rsmd</th><th rowspan="1" colspan="1">Hydrogen Bonding Residues</th><th rowspan="1" colspan="1">Hydrophobic Bonding Residues</th><th rowspan="1" colspan="1">Binding Affinity &#x02206;G Kcal/mol</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>3b</bold></td><td rowspan="1" colspan="1">1.07842</td><td rowspan="1" colspan="1">Try87 (O)<break/>Asp118 (S)</td><td rowspan="1" colspan="1">Phe62<break/>Trp87<break/>His116<break/>His179<break/>Ala212</td><td rowspan="1" colspan="1">&#x02212;6.0504</td></tr><tr><td rowspan="1" colspan="1">Lmp <bold>(Standard inhibitor)</bold></td><td rowspan="1" colspan="1">3.1247</td><td rowspan="1" colspan="1">Trp87 (O)<break/>Asp118 (O)</td><td rowspan="1" colspan="1">Phe62<break/>Asp63<break/>His146<break/>His240</td><td rowspan="1" colspan="1">&#x02212;5.8945</td></tr></tbody></table></table-wrap></p><p>The docked active pocket had 15 residues, and the target ligand <bold>(3b</bold>) interacted with 10 residues in the active pocket. The ligand (<bold>3b</bold>) showed two hydrogen bonds with Trp87 and Asp118, both with the oxygen of the sulphonyl group. Pi-Sulphur interaction was shown by Phe62, His116 and His179. A pi-cation interaction was found to be developed between the Zn302 of the target protein and the sulphur of the sulphonyl group as well as the sulphur of the thiophene group of docked compounds, respectively. Whereas a &#x003c0;-&#x003c0; interaction was established between the thiophene ring and His116 amino acid residue. About four alkyl and &#x003c0;-alkyl linkages were found with Phe62, Trp87, His116 and Ala212. Water-hydrogen bonding was shown by HOH-445, as described in <xref rid="f0004" ref-type="fig">Figure 4</xref>.
<fig position="float" id="f0003" fig-type="figure"><label>Figure 3</label><caption><p>Anti-bacterial activity of compound (<bold>3b</bold>) against CRKP pathogen.</p></caption><graphic xlink:href="IDR-17-2943-g0004" content-type="print-only" position="float"/></fig>
<fig position="float" id="f0004" fig-type="figure"><label>Figure 4</label><caption><p>The left side of the image shows 3D interaction and the right side shows the 2D interaction of ligand (<bold>3b</bold>) with amino acid residues of the pocket. Interaction with zinc and water is clearly shown in the 2D demonstration.</p></caption><graphic xlink:href="IDR-17-2943-g0005" content-type="print-only" position="float"/></fig></p><p>Validation was done by redocking the Standard inhibitor LMP in the active pocket of crystal structure protein. The best-docked pose of the standard inhibitor showed interaction with two hydrogen bonds with Trp87, Asp118, one &#x003c0;-alkyl interaction with His116, and one C-H interaction with Asp63. In addition to it, cofactor Zn also interacts with the docked molecule through &#x003c0;-cation interaction, as demonstrated in <xref rid="f0005" ref-type="fig">Figure 5</xref>. The binding free energy of this docked pose was found &#x02212;5.8945 kcal/mol, and the RSMD value was found 3.1247 A&#x000b0; (<xref rid="t0005" ref-type="table">Table 5</xref>).
<fig position="float" id="f0005" fig-type="figure"><label>Figure 5</label><caption><p>The left side shows 3D interaction, and the right shows the 2D interaction of standard inhibitor (LMP) with residues present in the active pocket. Yellow-coloured ball showing Zinc metal in the 3D active pocket.</p></caption><graphic xlink:href="IDR-17-2943-g0006" content-type="print-only" position="float"/></fig></p></sec></sec><sec id="s0004"><title>Discussion</title><p>As demonstrated by our earlier research, formamide is among the best medications for treating pathogens that are resistant to medications. According to our research on the biofilm inhibitory efficacy of aryl groups against Bacillus subtilis and Escherichia coli, they function as growth sites and feature hydrophobic (nonpolar) interactions. Amides simultaneously kill bacteria or cause stagnant growth and have a positive inhibitory impact.<xref rid="cit0042" ref-type="bibr">42</xref></p><p>Amides contain a hydrophilic binding site for bacterial enzyme proteins. Additionally, in order to evaluate the efficacy of this stent, we also looked at N, O, and S heterocyclic formamides. Further, we studied the <italic toggle="yes">N, O</italic>, and <italic toggle="yes">S</italic> heterocycles carboxamides like 2-aryl-4-chlorophenyl-5-arylthiophene-2-carboxylates<xref rid="cit0043" ref-type="bibr">43</xref>
<italic toggle="yes">N</italic>-(4-bromophenyl)furan-2-carboxamide,<xref rid="cit0037" ref-type="bibr">37</xref>
<italic toggle="yes">N</italic>-(4-methylpyridin-2-yl) Thiophene-2-Carboxamide 4-bromo-<italic toggle="yes">N</italic>-(5-methyl-1H-pyrazol-3-yl)benzamide<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0044" ref-type="bibr">44</xref> to study the effectiveness of these scaffolds. The drug is effective against <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic>, as well as resistant strains of <italic toggle="yes">Salmonella enterica, Acinetobacter baumannii, Enterobacter cloacae</italic>, and E. coli. The importance of heterocyclic formamide in antibacterial action was discovered. In the present world, synthetic small molecules play a crucial role in drug development for reasons related to the economy and the environment. As a result, we created a molecule that permits the chemical to grow in bacterial cells by adding a linear alkyl group. When the N-heterocyclic amide moiety becomes hydrophilic, it may attach itself to the proteins of bacteria. Some of the thiophene and sulfonamide derivatives that were reported to exhibit anti-bacterial activities are given in <xref rid="f0006" ref-type="fig">Figure 6</xref>. Moreover, sulfonamides have more polar surface area and better hydrogen bond acceptors.<xref rid="cit0045" ref-type="bibr">45</xref> Then, we envisioned the principle of a drug molecule containing a lipophilic tail and polar head. So, we synthesized a series of sulfonamides containing lipophilic tail and arylation of 5-bromo-<italic toggle="yes">N</italic>-propylthiophene-2-sulfonamides to evaluate the antibacterial activity of the synthesized compounds against NDM-1 producing <italic toggle="yes">K. pneumoniae</italic>. Our motivation for this work was the biological significance of sulfonamides. The in-silico experiments further validated our findings.
<fig position="float" id="f0006" fig-type="figure"><label>Figure 6</label><caption><p>Some reported antibacterial that contain thiophene and sulfonamide moieties. The blue encircled moieties represent the sulphonamide functional group that is common in various commercially available antibacterial agents eg, Sulphanilamide, Sulfisoxazole and Sulfathiazole. Molecular docking studies revealed that this functional group exhibited the maximum interactions with the target proteins. In addition, thiophene (Red encircled moiety) containing compounds have also been reported as antibacterial agents and this moiety also exhibited strong interactions with the target proteins.<xref rid="cit0046" ref-type="bibr">46&#x02013;51</xref></p></caption><graphic xlink:href="IDR-17-2943-g0007" content-type="print-only" position="float"/></fig></p></sec><sec id="s0005"><title>Conclusion</title><p>In this study, we successfully synthesized 5-bromo-<italic toggle="yes">N</italic>-alkylthiophene-2-sulfonamides (<bold>3a-c</bold>) in good yields (62&#x02013;78%) and found the compound (<bold>3b</bold>) as a potential drug candidate having zone inhibition (23&#x000b1;1.5mg/mL), MIC (0.39 &#x003bc;g/mL) and MBC (0.78 &#x003bc;g/mL) against NDM producing <italic toggle="yes">K. pneumoniae ST147</italic>. So, we synthesized a library of compounds (<bold>4a-g</bold>) by the arylation of <bold>3b</bold> via SMC coupling in moderate yields (56&#x02013;72%). But they do have not more promising activities like <bold>3b</bold>. It may be due to adding an extra aryl ring, which may cause steric hindrance upon attachment to the bacterial enzyme pocket. The in-silico studies also revealed that the target compound <bold>3b</bold> showed interactions other than standard inhibitors, such as water bridging. Moreover, it showed hydrophobic pi-donor with Zinc 302; therefore, it is concluded that <bold>3b</bold> proved to be a more potent drug than a standard inhibitor. These studies have demonstrated that sulfonamide is a promising class of antibiotics that can combat antibiotic-resistant bacterial strains.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to extend their sincere appreciation to the Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia for funding this work through project number (RSP2024R457). The data reported herein is part of the Ph.D. thesis research work of Dr. Mnaza Noreen.</p></ack><sec sec-type="COI-statement" id="s0006"><title>Disclosure</title><p>The authors declare no conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Sefton</surname>
<given-names>AM</given-names></string-name>. <article-title>Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium</article-title>. <source><italic toggle="yes">Drugs</italic></source>. <year>2002</year>;<volume>62</volume>(<issue>4</issue>):<fpage>557</fpage>&#x02013;<lpage>566</lpage>. doi:<pub-id pub-id-type="doi">10.2165/00003495-200262040-00001</pub-id><pub-id pub-id-type="pmid">11893225</pub-id>
</mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Tenover</surname>
<given-names>FC</given-names></string-name>. <article-title>Mechanisms of antimicrobial resistance in bacteria</article-title>. <source><italic toggle="yes">Am j Med</italic></source>. <year>2006</year>;<volume>119</volume>(<issue>6</issue>):<fpage>S3&#x02013;10;DiscussionS62</fpage>&#x02013;<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjmed.2006.03.011</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Wilke</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Lovering</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Strynadka</surname>
<given-names>NC</given-names></string-name>. <article-title>Beta-lactam antibiotic resistance: a current structural perspective</article-title>. <source><italic toggle="yes">Curr Opin Microbiol</italic></source>. <year>2005</year>;<volume>8</volume>(<issue>5</issue>):<fpage>525</fpage>&#x02013;<lpage>533</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2005.08.016</pub-id><pub-id pub-id-type="pmid">16129657</pub-id>
</mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Kapoor</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Saigal</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Elongavan</surname>
<given-names>A</given-names></string-name>. <article-title>Action and resistance mechanisms of antibiotics: a guide for clinicians</article-title>. <source><italic toggle="yes">J Anaesthesiol Clin Pharmacol</italic></source>. <year>2017</year>;<volume>33</volume>(<issue>3</issue>):<fpage>300</fpage>&#x02013;<lpage>305</lpage>. doi:<pub-id pub-id-type="doi">10.4103/joacp.JOACP_349_15</pub-id><pub-id pub-id-type="pmid">29109626</pub-id>
</mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Venter</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>S</given-names></string-name>. <article-title>Efflux pump inhibitors: a novel approach to combat efflux-mediated drug resistance in bacteria</article-title>. <source><italic toggle="yes">Curr Drug Targ</italic></source>. <year>2016</year>;<volume>17</volume>(<issue>6</issue>):<fpage>702</fpage>&#x02013;<lpage>719</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1389450116666151001103948</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Mahmood</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Jamshidi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sutton</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Rahman</surname>
<given-names>KM</given-names></string-name>. <article-title>Current advances in developing inhibitors of bacterial multidrug efflux pumps</article-title>. <source><italic toggle="yes">Curr. Med. Chem.</italic></source>
<year>2016</year>;<volume>23</volume>(<issue>10</issue>):<fpage>1062</fpage>&#x02013;<lpage>1081</lpage>. doi:<pub-id pub-id-type="doi">10.2174/0929867323666160304150522</pub-id><pub-id pub-id-type="pmid">26947776</pub-id>
</mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Sawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kooguchi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Moriyama</surname>
<given-names>K</given-names></string-name>. <article-title>Molecular diversity of extended-spectrum beta-lactamases and carbapenemases, and antimicrobial resistance</article-title>. <source><italic toggle="yes">J Intens Care</italic></source>. <year>2020</year>;<volume>8</volume>(<issue>1</issue>):<fpage>13</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40560-020-0429-6</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Gupta</surname>
<given-names>V</given-names></string-name>. <article-title>An update on newer &#x003b2;-lactamases</article-title>. <source><italic toggle="yes">Indian J Med Res</italic></source>. <year>2007</year>;<volume>126</volume>(<issue>5</issue>):<fpage>417</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">18160745</pub-id>
</mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Bush</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bradford</surname>
<given-names>PA</given-names></string-name>. <article-title>Interplay between &#x003b2;-lactamases and new &#x003b2;-lactamase inhibitors</article-title>. <source><italic toggle="yes">Nat Rev Microbiol</italic></source>. <year>2019</year>;<volume>17</volume>(<issue>5</issue>):<fpage>295</fpage>&#x02013;<lpage>306</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41579-019-0159-8</pub-id><pub-id pub-id-type="pmid">30837684</pub-id>
</mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Martin</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Alvarez-Alvarez</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Liras</surname>
<given-names>P</given-names></string-name>. <article-title>Penicillin-binding proteins, &#x003b2;-Lactamases, and &#x003b2;-Lactamase Inhibitors in &#x003b2;-Lactam-producing actinobacteria: self-resistance mechanisms</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2022</year>;<volume>23</volume>(<issue>10</issue>):<fpage>5662</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms23105662</pub-id><pub-id pub-id-type="pmid">35628478</pub-id>
</mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Bahr</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gonzalez</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Vila</surname>
<given-names>AJ</given-names></string-name>. <article-title>Metallo-&#x003b2;-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design</article-title>. <source><italic toggle="yes">Chem Rev</italic></source>. <year>2021</year>;<volume>121</volume>(<issue>13</issue>):<fpage>7957</fpage>&#x02013;<lpage>8094</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.chemrev.1c00138</pub-id><pub-id pub-id-type="pmid">34129337</pub-id>
</mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Almeida</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dhillon-LaBrooy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Castro</surname>
<given-names>CN</given-names></string-name>, et al. <article-title>Ribosome-targeting antibiotics impair T cell effector function and ameliorate autoimmunity by blocking mitochondrial protein synthesis</article-title>. <source><italic toggle="yes">Immunity</italic></source>. <year>2021</year>;<volume>54</volume>(<issue>1</issue>):<fpage>68</fpage>&#x02013;<lpage>83.e66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2020.11.001</pub-id><pub-id pub-id-type="pmid">33238133</pub-id>
</mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Schaenzer</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>GD</given-names></string-name>. <article-title>Antibiotic resistance by enzymatic modification of antibiotic targets</article-title>. <source><italic toggle="yes">Trends Mol Med</italic></source>. <year>2020</year>;<volume>26</volume>(<issue>8</issue>):<fpage>768</fpage>&#x02013;<lpage>782</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molmed.2020.05.001</pub-id><pub-id pub-id-type="pmid">32493628</pub-id>
</mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Sati</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Sarpe</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Furukawa</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Modification at the 2&#x02032;-position of the 4, 5-series of 2-deoxystreptamine aminoglycoside antibiotics to resist aminoglycoside modifying enzymes and increase ribosomal target selectivity</article-title>. <source><italic toggle="yes">ACS Infect Dis</italic></source>. <year>2019</year>;<volume>5</volume>(<issue>10</issue>):<fpage>1718</fpage>&#x02013;<lpage>1730</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00128</pub-id><pub-id pub-id-type="pmid">31436080</pub-id>
</mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Wilson</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Hauryliuk</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Atkinson</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>J</surname>
<given-names>A</given-names></string-name>. <article-title>O&#x02019;Neill, Target protection as a key antibiotic resistance mechanism</article-title>. <source><italic toggle="yes">Nat Rev Microbiol</italic></source>. <year>2020</year>;<volume>18</volume>(<issue>11</issue>):<fpage>637</fpage>&#x02013;<lpage>648</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41579-020-0386-z</pub-id><pub-id pub-id-type="pmid">32587401</pub-id>
</mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Ahmad</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Rasool</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Qamar</surname>
<given-names>MU</given-names></string-name>, et al. <article-title>Facile synthesis of 4-aryl-N-(5-methyl-1H-pyrazol-3-yl)benzamides via Suzuki Miyaura reaction: antibacterial activity against clinically isolated NDM-1-positive bacteria and their Docking Studies</article-title>. <source><italic toggle="yes">Arabian J Chem</italic></source>. <year>2021</year>;<volume>14</volume>(<issue>8</issue>):<fpage>103270</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arabjc.2021.103270</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mathema</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Chavda</surname>
<given-names>KD</given-names></string-name>, <string-name><surname>DeLeo</surname>
<given-names>FR</given-names></string-name>, <string-name><surname>Bonomo</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Kreiswirth</surname>
<given-names>BN</given-names></string-name>. <article-title>Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding</article-title>. <source><italic toggle="yes">Trend Microbiol</italic></source>. <year>2014</year>;<volume>22</volume>(<issue>12</issue>):<fpage>686</fpage>&#x02013;<lpage>696</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tim.2014.09.003</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Wyres</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Holt</surname>
<given-names>KE</given-names></string-name>. <article-title>Population genomics of Klebsiella pneumoniae</article-title>. <source><italic toggle="yes">Nat Rev Microbiol</italic></source>. <year>2020</year>;<volume>18</volume>(<issue>6</issue>):<fpage>344</fpage>&#x02013;<lpage>359</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41579-019-0315-1</pub-id><pub-id pub-id-type="pmid">32055025</pub-id>
</mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Nordmann</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cuzon</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Naas</surname>
<given-names>T</given-names></string-name>. <article-title>The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria</article-title>. <source><italic toggle="yes">Lancet Infect Dis</italic></source>. <year>2009</year>;<volume>9</volume>(<issue>4</issue>):<fpage>228</fpage>&#x02013;<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(09)70054-4</pub-id><pub-id pub-id-type="pmid">19324295</pub-id>
</mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Qiao</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae</article-title>. <source><italic toggle="yes">Clinl Infect Dis</italic></source>. <year>2018</year>;<volume>67</volume>(<issue>suppl_2</issue>):<fpage>S225</fpage>&#x02013;<lpage>S230</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/ciy642</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Schwaber</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Klarfeld-Lidji</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Navon-Venezia</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Leavitt</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Carmeli</surname>
<given-names>Y</given-names></string-name>. <article-title>Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality</article-title>. <source><italic toggle="yes">Antimicrob Agents Chemother</italic></source>. <year>2008</year>;<volume>52</volume>(<issue>3</issue>):<fpage>1028</fpage>&#x02013;<lpage>1033</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01020-07</pub-id><pub-id pub-id-type="pmid">18086836</pub-id>
</mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Peirano</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Kreiswirth</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Pitout</surname>
<given-names>JD</given-names></string-name>. <article-title>Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147</article-title>. <source><italic toggle="yes">Antimicrob Agents Chemother</italic></source>. <year>2020</year>;<volume>64</volume>(<issue>10</issue>):<fpage>e01148</fpage>&#x02013;<lpage>01120</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01148-20</pub-id><pub-id pub-id-type="pmid">32747358</pub-id>
</mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>de Barsy</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mercuri</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Oueslati</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Detection and Characterization of VIM-52, a New Variant of VIM-1 from a Klebsiella pneumoniae Clinical Isolate</article-title>. <source><italic toggle="yes">Antimicrob Agents Chemother</italic></source>. <year>2021</year>;<volume>65</volume>(<issue>11</issue>):<fpage>e02660</fpage>&#x02013;<lpage>02620</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.02660-20</pub-id><pub-id pub-id-type="pmid">34370584</pub-id>
</mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="newspaper"><string-name><surname>Connor</surname>
<given-names>EE</given-names></string-name>, <article-title>Sulfonamide antibiotics, Primary care update for ob/gyns</article-title>. <year>1998</year>:<fpage>32</fpage>&#x02013;<lpage>35</lpage>.</mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Debnath</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Roy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Purkayastha</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Synthesis and structure of 1, 3-dimethyl-5-(p-sulfonamide-phenylazo)-6-aminouracil and its Ni (II) complex: topological insights and investigation for noncovalent interactions</article-title>. <source><italic toggle="yes">J Mol Struct</italic></source>. <year>2017</year>;<volume>1141</volume>(<issue>1141</issue>):<fpage>225</fpage>&#x02013;<lpage>236</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molstruc.2017.03.121</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Boufas</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Dupont</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Berredjem</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Synthesis and antibacterial activity of sulfonamides. SAR and DFT studies</article-title>. <source><italic toggle="yes">SAR and DFT Studies, Journal of Molecular Structure</italic></source>. <year>2014</year>;<volume>1074</volume>:<fpage>180</fpage>&#x02013;<lpage>185</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molstruc.2014.05.066</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Yousef</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Mansour</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Herbali</surname>
<given-names>J</given-names></string-name>. <article-title>Sulfonamides: historical discovery development (structure-activity relationship notes</article-title>. <source><italic toggle="yes">In vitro In vivo In Silico J</italic></source>. <year>2018</year>;<volume>1</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Fern&#x000e1;ndez-Villa</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Aguilar</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Rojo</surname>
<given-names>L</given-names></string-name>. <article-title>Folic acid antagonists: antimicrobial and immunomodulating mechanisms and applications</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2019</year>;<volume>20</volume>(<issue>20</issue>):<fpage>4996</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms20204996</pub-id><pub-id pub-id-type="pmid">31601031</pub-id>
</mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Michelini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>La Rocca</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rascio</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ghisi</surname>
<given-names>R</given-names></string-name>. <article-title>Structural and functional alterations induced by two sulfonamide antibiotics on barley plants</article-title>. <source><italic toggle="yes">Plant Physiol Biochem</italic></source>. <year>2013</year>;<volume>67</volume>:<fpage>55</fpage>&#x02013;<lpage>62</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.plaphy.2013.02.027</pub-id><pub-id pub-id-type="pmid">23542184</pub-id>
</mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Cheng</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>H</given-names></string-name>. <article-title>Recent advances in the use of photochromic dyes for photocontrol in biomedicine</article-title>. <source><italic toggle="yes">Coord Chem Rev</italic></source>. <year>2018</year>;<volume>372</volume>:<fpage>66</fpage>&#x02013;<lpage>84</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2018.06.003</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Cui</surname>
<given-names>ZH</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>WG</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>BT</given-names></string-name>. <article-title>Application of orange phenylazo-&#x003b2;-naphthol-containing sulfonamide disperse dyes designed for poly (lactic acid)</article-title>. <source><italic toggle="yes">Advanced Materials Research</italic></source>. <year>2012</year>; <volume>441</volume>:<fpage>503</fpage>&#x02013;<lpage>507</lpage>.</mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Rehman</surname>
<given-names>AU</given-names></string-name>, <string-name><surname>Tanveer</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Abbasi</surname>
<given-names>MA</given-names></string-name>, et al. <article-title>Synthesis, characterization and biological screening of various N-substituted derivatives of sulfonamides</article-title>. <source><italic toggle="yes">Int J Chem Res</italic></source>. <year>2011</year>;<volume>2</volume>:<fpage>3</fpage>.</mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>T&#x000f9;ng</surname>
<given-names>&#x00110;T</given-names></string-name>, <string-name><surname>Tu&#x000e2;n</surname>
<given-names>&#x00110;T</given-names></string-name>, <string-name><surname>Rasool</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Regioselective palladium (0)&#x02010;catalyzed cross&#x02010;coupling reactions and metal&#x02010;halide exchange reactions of tetrabromothiophene: optimization, scope and limitations</article-title>. <source><italic toggle="yes">Adv Synth Catal</italic></source>. <year>2009</year>;<volume>351</volume>(<issue>10</issue>):<fpage>1595</fpage>&#x02013;<lpage>1609</lpage>. doi:<pub-id pub-id-type="doi">10.1002/adsc.200900044</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="newspaper"><string-name><surname>Melvin</surname>
<given-names>JSL</given-names></string-name>. <article-title>Humphries, Performance Standards for Antimicrobial Susceptibility Testing</article-title>. <source>Clinical Laboratory Standard institute supplement M100</source>; <year>2021</year>.</mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Qamar</surname>
<given-names>MU</given-names></string-name>, <string-name><surname>Walsh</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Toleman</surname>
<given-names>MA</given-names></string-name>, et al. <article-title>Dissemination of genetically diverse NDM-1, &#x02212;5, &#x02212;7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan</article-title>. <source><italic toggle="yes">Future Microbiol</italic></source>. <year>2019</year>;<volume>14</volume>(<issue>8</issue>):<fpage>691</fpage>&#x02013;<lpage>704</lpage>. doi:<pub-id pub-id-type="doi">10.2217/fmb-2019-0012</pub-id><pub-id pub-id-type="pmid">31148474</pub-id>
</mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Qamar</surname>
<given-names>MU</given-names></string-name>, <string-name><surname>Saleem</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Toleman</surname>
<given-names>MA</given-names></string-name>, et al. <article-title>In Vitro and in Vivo Activity of Manuka Honey against NDM-1-Producing Klebsiella Pneumoniae ST11</article-title>. <source><italic toggle="yes">Future Microbiol</italic></source>. <year>2018</year>;<volume>13</volume>(<issue>1</issue>):<fpage>13</fpage>&#x02013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.2217/fmb-2017-0119</pub-id><pub-id pub-id-type="pmid">29226698</pub-id>
</mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="newspaper"><string-name><surname>Siddiqa</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zubair</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bilal</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Synthesis of Functionalized N-(4-Bromophenyl)furan-2-carboxamides via Suzuki-Miyaura Cross-Coupling: anti-Bacterial Activities against Clinically Isolated Drug Resistant A</article-title>. <source>K. pneumoniae, E. cloacae and MRSA and Its Validation via a Computational Approach, Pharmaceuticals</source>; <year>2022</year>:<fpage>841</fpage>.</mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Van De Waterbeemd</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Gifford</surname>
<given-names>E</given-names></string-name>. <article-title>ADMET in silico modelling: towards prediction paradise?</article-title>
<source><italic toggle="yes">Nat Rev Drug Discov</italic></source>. <year>2003</year>;<volume>2</volume>(<issue>3</issue>):<fpage>192</fpage>&#x02013;<lpage>204</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrd1032</pub-id><pub-id pub-id-type="pmid">12612645</pub-id>
</mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Uddin</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Mazharol Hoque</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Halim</surname>
<given-names>MA</given-names></string-name>. <article-title>Halogenated derivatives of methotrexate as human dihydrofolate reductase inhibitors in cancer chemotherapy</article-title>. <source><italic toggle="yes">J Biomol Struct Dyn</italic></source>. <year>2020</year>;<volume>38</volume>(<issue>3</issue>):<fpage>901</fpage>&#x02013;<lpage>917</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07391102.2019.1591302</pub-id><pub-id pub-id-type="pmid">30938661</pub-id>
</mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Yunta</surname>
<given-names>MJ</given-names></string-name>. <article-title>It is important to compute intramolecular hydrogen bonding in drug design</article-title>. <source><italic toggle="yes">Am J Model Optim</italic></source>. <year>2017</year>;<volume>5</volume>:<fpage>24</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Melgarejo</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Cardoso</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Pinto</surname>
<given-names>IB</given-names></string-name>, et al. <article-title>Identification, molecular characterization, and structural analysis of the bla NDM-1 gene/enzyme from NDM-1-producing Klebsiella pneumoniae isolates</article-title>. <source><italic toggle="yes">J Anti</italic></source>. <year>2019</year>;<volume>72</volume>(<issue>3</issue>):<fpage>155</fpage>&#x02013;<lpage>163</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41429-018-0126-z</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Ejaz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zubair</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rasool</surname>
<given-names>N</given-names></string-name>, et al. <article-title>N&#x02010;([1, 1&#x002b9;&#x02010;biaryl]&#x02010;4&#x02010;yl)&#x02010;1&#x02010;naphthamide&#x02010;based scaffolds synthesis, their cheminformatics analyses, and screening as bacterial biofilm inhibitor</article-title>. <source><italic toggle="yes">J Basic Microbiol</italic></source>. <year>2022</year>;<volume>62</volume>:<fpage>1143</fpage>&#x02013;<lpage>1155</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jobm.202100288</pub-id><pub-id pub-id-type="pmid">34724237</pub-id>
</mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Mujahid</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rasool</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Qamar</surname>
<given-names>MU</given-names></string-name>, et al. <article-title>Arylation of halogenated thiophene carboxylate via Suzuki&#x02013;Miyaura reaction: anti-bacterial study against clinically isolated extensively drug resistant Escherichia coli sequence type 405 and computational investigation</article-title>. <source><italic toggle="yes">Arabian J Chem</italic></source>. <year>2022</year>;<volume>15</volume>(<issue>3</issue>):<fpage>103662</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arabjc.2021.103662</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Ahmad</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Khalid</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Qamar</surname>
<given-names>MU</given-names></string-name>, et al. <article-title>Antibacterial Efficacy of N-(4-methylpyridin-2-yl) Thiophene-2-Carboxamide Analogues against Extended-Spectrum-&#x003b2;-Lactamase Producing Clinical Strain of Escherichia coli ST 131</article-title>. <source><italic toggle="yes">Molecules</italic></source>. <year>2023</year>;<volume>28</volume>(<issue>7</issue>):<fpage>3118</fpage>. doi:<pub-id pub-id-type="doi">10.3390/molecules28073118</pub-id><pub-id pub-id-type="pmid">37049881</pub-id>
</mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Pedersen</surname>
<given-names>PS</given-names></string-name>, <string-name><surname>Blakemore</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Chinigo</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Knauber</surname>
<given-names>T</given-names></string-name>, <string-name><surname>MacMillan</surname>
<given-names>DW</given-names></string-name>. <article-title>One-pot synthesis of sulfonamides from unactivated acids and amines via aromatic decarboxylative halosulfonylation</article-title>. <source><italic toggle="yes">J Am Chem Soc</italic></source>. <year>2023</year>;<volume>145</volume>(<issue>39</issue>):<fpage>21189</fpage>&#x02013;<lpage>21196</lpage>. doi:<pub-id pub-id-type="doi">10.1021/jacs.3c08218</pub-id><pub-id pub-id-type="pmid">37729614</pub-id>
</mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Wainwright</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kristiansen</surname>
<given-names>JE</given-names></string-name>. <article-title>On the 75th anniversary of Prontosil</article-title>. <source><italic toggle="yes">Dyes Pigm.</italic></source>
<year>2011</year>;<volume>88</volume>(<issue>3</issue>):<fpage>231</fpage>&#x02013;<lpage>234</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.dyepig.2010.08.012</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Noreen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rasool</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Gull</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>A facile synthesis of new 5-aryl-thiophenes bearing sulfonamide moiety via Pd (0)-catalyzed Suzuki&#x02013;Miyaura cross coupling reactions and 5-bromothiophene-2-acetamide: as potent urease inhibitor, antibacterial agent and hemolytically active compounds</article-title>. <source><italic toggle="yes">J Saudi Chem Soc</italic></source>. <year>2017</year>;<volume>21</volume>:<fpage>S403</fpage>&#x02013;<lpage>S414</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jscs.2014.04.007</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Mishra</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sachan</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Thiophene scaffold as prospective antimicrobial agent</article-title>. <source><italic toggle="yes">Rev J Heterocy Chem</italic></source>. <year>2018</year>;<volume>55</volume>(<issue>9</issue>):<fpage>2019</fpage>&#x02013;<lpage>2034</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jhet.3249</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Roman</surname>
<given-names>G</given-names></string-name>. <article-title>Thiophene&#x02010;containing compounds with antimicrobial activity</article-title>. <source><italic toggle="yes">Arch. Pharm.</italic></source>
<year>2022</year>;<volume>355</volume>(<issue>6</issue>):<fpage>2100462</fpage>. doi:<pub-id pub-id-type="doi">10.1002/ardp.202100462</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Bishoyi</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Mahapatra</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sahoo</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Paidesetty</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Padhy</surname>
<given-names>RN</given-names></string-name>. <article-title>Design, molecular docking and antimicrobial assessment of newly synthesized p-cuminal-sulfonamide Schiff base derivatives</article-title>. <source><italic toggle="yes">J Mol Struct</italic></source>. <year>2022</year>;<volume>1250</volume>:<fpage>131824</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molstruc.2021.131824</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="newspaper"><string-name><surname>Nayab</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alam</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ahmad</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Thiophene-derived Schiff base complexes: synthesis, characterization, antimicrobial properties, and molecular docking, ACS omega</article-title>; <year>2023</year>.</mixed-citation></ref></ref-list></back></article>